Beyond Vasoprotection: Statins and Risk Reduction for Community-Acquired Staphylococcus aureus Bacteremia

Mayo Clin Proc. 2017 Oct;92(10):1463-1465. doi: 10.1016/j.mayocp.2017.08.013.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Bacteremia
  • Community-Acquired Infections
  • Cross Infection
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Risk Factors
  • Risk Reduction Behavior
  • Staphylococcal Infections
  • Staphylococcus aureus*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors